Found: 16
Select item for more details and to access through your institution.
Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 718, doi. 10.1002/ejhf.809
- By:
- Publication type:
- Article
Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 760, doi. 10.1002/ejhf.746
- By:
- Publication type:
- Article
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 800, doi. 10.1002/ejhf.830
- By:
- Publication type:
- Article
Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 792, doi. 10.1002/ejhf.688
- By:
- Publication type:
- Article
Current Approach to Heart Failure.
- Published in:
- 2017
- By:
- Publication type:
- Book Review
Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 728, doi. 10.1002/ejhf.766
- By:
- Publication type:
- Article
High-density lipoprotein-associated paraoxonase 1: a possible prognostic biomarker for heart failure?
- Published in:
- 2017
- By:
- Publication type:
- Editorial
What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 768, doi. 10.1002/ejhf.788
- By:
- Publication type:
- Article
Should recommendations for clinical use be restricted to patients who were enrolled in a pivotal clinical trial?
- Published in:
- 2017
- By:
- Publication type:
- Editorial
June 2017 at a glance: biomarkers and medical treatment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 748, doi. 10.1002/ejhf.777
- By:
- Publication type:
- Article
Circular RNAs in heart failure.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 701, doi. 10.1002/ejhf.801
- By:
- Publication type:
- Article
Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 710, doi. 10.1002/ejhf.799
- By:
- Publication type:
- Article
Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure--does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS)
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 739, doi. 10.1002/ejhf.786
- By:
- Publication type:
- Article
Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article